Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 30, 2015
Patent Application Number
12295718
Date Filed
April 2, 2007
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to the use of an antibody which can specifically bind to chemokine receptor CCR2 for producing a medicament utilized for the treatment of multiple sclerosis and/or rheumatoid arthritis in a subject that is preferably a primate or a human. In another embodiment, the invention relates to the use of an antibody which can specifically bind to chemokine receptor CCR2 for producing a medicament that is utilized for depleting monocytes in subjects suffering from multiple sclerosis and/or rheumatoid arthritis. The invention further relates to corresponding in vitro methods and therapeutic methods. And antibody which binds to CD 14, for example, can be used in addition to the antibody that can bind to CCR2.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
